Career

Envision the tomorrow of cancer therapy with innovative and new challenges

-Career

Involved in the establishment of the company as a founding member of Chordia Therapeutics in November 2017 after engaging in drug discovery research in the oncology area at a pharmaceutical company.

-Job

Conducting research and development of novel anti-cancer drugs. If the process from R & D to sales of a new drug is divided into 10 stages, we take are 1 to 5 or 6 steps.
I am in charge of creating the first concept for new drug development, and conducting research and development based on that concept.
Currently, we are conducting research and development on oral anti-cancer drugs.
With the desire to “deliver effective new drugs to patients suffering from cancer as soon as possible,” we are conducting research and development on a daily basis with our reliable colleagues.
I am also involved in company management as a CSO that is the brain of the CEO, so I’m executing strategy planning, and research and development with a sense of speed.

Until now, one pharmaceutical company in Japan has been in charge of all processes from research and development to sales of new drugs. However, in the last five years or so, the number of venture companies (startup ventures) that are only in charge of the research and development field has increased, and we are one of them.
The advantage of working at Chordia Therapeutics is, above all, the speed of decision making. As soon as we think about the concept of a new drug and decide on a path to believe in it, we just initiate research and execute toward our goals. For large companies, innovation and novelty are often regarded as risks, but it is no exaggeration to say that it is in the interest of researchers to be able to tackle new challenges with a sense of speed. Every day, I feel a sense of mission and worthwhile to be able to work with selected small number of experienced colleagues while having a spirit of challenge.

Cultivating seeds for new medicines and taking on the challenge of developing attractive new anti-cancer medicines.

-Career

Joined Chordia Therapeutics in May 2018 after engaging in pharmacological research mainly in the areas of lifestyle-related diseases and oncology at a pharmaceutical company.

-Job

We are conducting pharmacological research to evaluate whether compounds synthesized based on the concept of new drug development act properly on the target and exert therapeutic effects. So to speak, it is a job to investigate and nurture whether “seed”, which is the pre-stage of medicine, can grow as a new medicine. In addition to pharmacological research, we are also conducting safety evaluations as a medicine and searching for biomarkers that can be applied to clinical trials.
In addition to experiments, there are many opportunities for contacting with external stakeholders, such as interactions with collaborative research partners such as academia and subcontractors who have requested evaluation, and there are a wide variety of work contents such as report creation and project control.

Even with the same drug discovery research, in the case of a large organization, it often took time to make a decision on planning and executing each research. However, in the case of Chordia Therapeutics, the decision making is quick, and when the concept is decided, “ Go” comes out immediately, so you can concentrate only on the direction you are going. On the other hand, drug discovery research is the preceding research, so it often does not go as expected. However, we do not regard it as a minus, and we have a culture in which we can immediately switch to thinking “how can it work?” And move forward.
Oncology research is a life-threatening job. I face my work every day with the hope that growing seeds of new drugs will lead to human life and social contribution.

Eager to support the growth of the company as a specialist in the corporate function

-Career

Eager to support the growth of the company as a specialist in the corporate function

-Job

I am involved in general corporate operations such as IR, general affairs, and legal affairs, with a focus on accounting and finance. At a major audit firm I used to work for especially accounting-specific operations, but after joining Chordia Therapeutics, I was involved in all operations other than research and development, as well as operations related to accounting. Since we are planning an IPO, it is also a big mission for me to do the work of preparing the company structure for the initial public offering.

After gaining experience at a major audit firm and gaining a base as an accounting professional, I had always wanted to take advantage of my career and work in a venture business. In addition, since my brother is a medical doctor and a researcher in oncology area, so I’m also interested in the medical field. At that time, I had opportunity to connect with Chordia’s team so I felt to be fated and decided to join the compan
The appeal of our company is that human resources with high skills and deep knowledge face their work with the passion and venture splits. In addition, the comfortable atmosphere, where gentle employees can easily talk about their private lives could be quite attractive. In a few elite environments, each person’s responsibilities increase, and the members at Chordia Therapeutics enjoy it and think about what they can do for the company. The growth of the company also leads to my own growth. Chordia Therapeutics is a company where you can feel it.